Exagen Inc. (XGN) stock
XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$3.90+0.14 (+3.72%)
Close on Nov 18, 2026Market cap $94.48MP/E –Yield –
Exagen net income
Net income is the profit left for shareholders after every expense, interest and tax.
Exagen's net income for the twelve months ending Jun 30, 2026 was -$18.92M. For fiscal 2025 it was -$19.95M. The highest annual figure on record is -$8.01M in fiscal 2018.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$19.95M | – |
| FY2024 | Dec 31, 2024 | -$15.12M | – |
| FY2023 | Dec 31, 2023 | -$23.69M | – |
| FY2022 | Dec 31, 2022 | -$47.39M | – |
| FY2021 | Dec 31, 2021 | -$26.85M | – |
| FY2020 | Dec 31, 2020 | -$16.69M | – |
| FY2019 | Dec 31, 2019 | -$12.04M | – |
| FY2018 | Dec 31, 2018 | -$8.01M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.20M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.97M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.67M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.09M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.44M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.75M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.76M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.03M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.97M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.36M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.57M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.42M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.01M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.69M | – |
| Q4 FY2022 | Dec 31, 2022 | -$14.35M | – |
| Q3 FY2022 | Sep 30, 2022 | -$8.10M | – |
| Q2 FY2022 | Jun 30, 2022 | -$14.67M | – |
| Q1 FY2022 | Mar 31, 2022 | -$10.27M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.05M | – |
| Q3 FY2021 | Sep 30, 2021 | -$7.18M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.41M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.21M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.45M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.31M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.36M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.56M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.41M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.14M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.79M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.70M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.32M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.76M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.15M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.79M | – |
See a number that looks wrong?